--- title: Phase I Clinical Trials CROs path: /services/phase-1-clinical-trials companies_count: 88 --- # Phase I Clinical Trials CROs 88 published CROs match Phase I Clinical Trials. Locations in this set include United States, United Kingdom, India, France, Australia, and Germany. Capabilities that show up most often in this set: Small Molecule, Biologics (Other), Gene Therapy, Cell Therapy, and Vaccine. ## Matching companies - [Accelsiors](/companies/accelsiors) - Full-service CRO providing clinical trial management, regulatory consulting, pharmacovigilance, biostatistics, and medical writing across 40+ countries with AI-secure eClinical systems and patient-centered trial design. - [Acromion Gmbh](/companies/acromion-gmbh) - European full-service CRO supporting clinical development from Phase I to IV and non-interventional studies, with expertise in clinical monitoring, data management, biostatistics, medical writing, and regulatory affairs. - [Advanced Clinical](/companies/advancedclinical) - Global CRO and FSP provider with 25+ years of experience delivering integrated clinical research solutions across North America, Europe, LATAM, and APAC. - [Aliri Bioanalysis](/companies/aliribio) - Bioanalytical CRO specializing in PK/PD, biomarker, and spatial imaging services across discovery through Phase 3 clinical trials, with 20+ years of regulatory expertise. - [Allucent](/companies/allucent) - Allucent is a full-service CRO specializing in clinical development solutions for small and mid-sized biotech companies. - [Altasciences](/companies/altasciences) - Mid-size early phase CRO/CDMO in Canada and the U.S. offering preclinical safety testing, clinical pharmacology (Phase I–II), bioanalysis, research services, and manufacturing with integrated capabilities. - [Avion](/companies/avion) - Full-service CRO specializing in clinical trial management, advanced medical imaging, dosimetry, and data management across oncology, dermatology, and radiopharmaceutical therapies. - [BioAgile Therapeutics](/companies/bioagiletherapeutics) - ISO 9001:2015-certified CRO offering end-to-end clinical research services including Phase I–IV trials, medical writing, biostatistics, data management, and regulatory support across pharmaceuticals, nutraceuticals, devices, and biotech. - [BioPharma Services Inc.](/companies/biopharmaservices) - Full-service Phase 1 CRO specializing in early-stage clinical trials, bioequivalence/bioavailability studies, and human abuse potential assessments with state-of-the-art facilities in Toronto and in-house bioanalytical labs. - [Biotrial](/companies/biotrial) - Biotrial is a leading CRO specializing in early-phase clinical development with 260 beds across Phase I units in France and the USA, offering First-in-Human studies, Proof-of-Concept trials, bioanalysis, biometrics, ECG, and CNS & imaging core lab services. - [CMIC HOLDINGS Co., Ltd.](/companies/cmicgroup) - CMIC HOLDINGS is a Japanese healthcare group whose Pharmaceutical Solutions cover consulting, non-clinical CRO, CRO, CDMO, SMO and CSO services. The group says it supports pharmaceutical companies across the value chain from non-clinical stages through post-marketing. - [CROss Alliance](/companies/croalliance) - Swiss-based CRO with over 500 completed clinical studies, specializing in Phase I research in healthy volunteers and special populations, supported by centralized clinical labs and analytical capabilities. - [CTI Clinical Trial and Consulting Services](/companies/ctifacts) - Full-service CRO founded in 1999 providing therapeutic expertise across clinical trial and consulting services to pharmaceutical and biotechnology companies. - [Caidya](/companies/caidya) - Caidya is a global, full-service CRO delivering personalized clinical development solutions across all phases of clinical research. - [Cardiovascular Clinical Sciences](/companies/ccstrials) - Specialized cardiovascular CRO offering full-spectrum clinical development from protocol design through regulatory submission, with deep cardiology expertise and core laboratory services across all development phases. - [Celerion](/companies/celerion) - Global CRO specializing in early-phase clinical research and bioanalytical sciences with 650+ beds across 30 countries and 50+ years of experience. - [Certara](/companies/certara) - Certara transforms drug development with proprietary biosimulation software, predictive modeling, and AI-driven services spanning discovery through commercialization. Serving 2,400+ biopharmaceutical companies and regulatory agencies across 70 countries, Certara's model-informed drug development (MIDD) platform accelerates clinical and regulatory decision-making. - [Champions Oncology](/companies/championsoncology) - Leading oncology CRO specializing in preclinical and clinical specialty testing, with over 1,400 patient-derived xenograft models, comprehensive multi-omic datasets, and proprietary platforms including flow cytometry, NGS, proteomics, and histopathology services. - [Citeline](/companies/citeline) - Citeline provides clinical trial intelligence, planning, feasibility, patient engagement, and regulatory compliance solutions to pharmaceutical sponsors. The platform delivers benchmarking across 400k+ trials, site selection, protocol optimization, and disclosure management services. - [Clarenta](/companies/comac-medical) - Clarenta (formerly Comac Medical Group) is a pan-European CRO offering full-service trial delivery and early-phase studies, including first-in-human and PK work. It runs a Phase I unit in Sofia and has depth in oncology and rare diseases.